- 1. MD
- [A country in Eastern Europe, northeast of Romania. (NCI) ( NCI )] (UMLS (NCI) C0026374) =Geographic Area ;
| - 16. MDM/ACK - Document edit notification
- (UMLS (HL7) C1549376) =Health Care Activity =Event Type;
|
- 2. MD-805
- (UMLS (NCI) C0127216) =Organic Chemical; Pharmacologic Substance
| - 17. MDM/ACK - Document edit notification and content
- (UMLS (HL7) C1549377) =Health Care Activity =Event Type;
|
- 3. MDFAttributeType
- (UMLS (HL7) C1553838) =Intellectual Product =CodeSystem;
=Desc;
Date and Time;
Code;
Communication Address;
Formal Expression;
Fraction;
Identifier;
Indicator;
Number;
Name;
Quantity;
Time Range;
General Timing;
Text;
Value;
Phone;
Address;
| - 18. MDM/ACK - Document replacement notification
- (UMLS (HL7) C1549378) =Health Care Activity =Event Type;
|
- 4. MdfHmdMetSourceType
- [Code to identify the source of a Message Element Type represented in the 'of MET' column of an HMD. ( HL7V3.0 )] (UMLS (HL7) C1553839) =Intellectual Product =CodeSystem;
=New type;
Common MET;
Re-used MET;
Recursive;
Reference;
Data type;
| - 19. MDM/ACK - Document replacement notification and content
- (UMLS (HL7) C1549379) =Health Care Activity =Event Type;
|
- 5. MdfHmdRowType
- [The row type codes for the tabular representation of a Hierarchical Message Description. ( HL7V3.0 )] (UMLS (HL7) C1553840) =Intellectual Product =CodeSystem;
=HMD identifier;
HMD root class;
Association Row;
Attribute Row;
Collection Item Row;
Subtype constraint;
| - 20. MDM/ACK - Document status change notification
- (UMLS (HL7) C1549372) =Health Care Activity =Event Type;
|
- 6. MdfRmimRowType
- [The row types for the tabular representation of an R-MIM. ( HL7V3.0 )] (UMLS (HL7) C1553841) =Intellectual Product =CodeSystem;
=RMIM identifier;
Class row;
Attribute row;
Association row;
Subtype constraint | - 21. MDM/ACK - Document status change notification and content
- (UMLS (HL7) C1549373) =Health Care Activity =Event Type;
|
- 7. MDFSubjectAreaPrefix
- [The standard prefixes used in Rose for RIM subject areas that determine the role or function of each subject area. ( HL7V3.0 )] (UMLS (HL7) C1553842) =Intellectual Product =CodeSystem;
=Stewardship;
Class of Interest;
Domain model;
RIM content;
| - 22. MDM/ACK - Original document notification
- (UMLS (HL7) C1549370) =Health Care Activity =Event Type;
|
- 8. MDK
- [This gene is involved in nervous tissue development. It plays a role in neuronal differentiation, growth, regeneration and survival. ( NCI )] (UMLS (NCI) C1334498) MDK Gene;
Midkine (Neurite Growth-Promoting Factor 2) Gene;
=Gene or Genome ;
| - 23. MDM/ACK - Original document notification and content
- (UMLS (HL7) C1549371) =Health Care Activity =Event Type;
|
- 9. MDL 101,731
- [A drug that belongs to a family of drugs called ribonucleotide reductase inhibitors. ( NCI )] (UMLS (NCI) C0969834) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
| - 24. MDM2
- [This gene plays a role in several cellular processes related to cellular viability; including the cell cycle and apoptosis. ( NCI )] (UMLS (NCI) C0812222) MDM2 Gene;
MDM2, Transformed 3T3 Cell Double Minute 2, p53 Binding Protein (Mouse) Gene;
=Gene or Genome |
- 10. MDL 18962
- (UMLS (NCI) C0127279) =Steroid; Pharmacologic Substance ;
| - 25. MDNS
- [Universal Medical Device Nomenclature System. ECRI, 5200 Butler Pike, Plymouth Meeting, PA 19462 USA. Phone: 215-825-6000, Fax: 215-834-1275. ( HL7V3.0 )] (UMLS (HL7) C1140120) =Intellectual Product =Code;
CodeSystem |
- 11. MDL 73,147EF
- (UMLS (NCI) C0740030) =Organic Chemical; Pharmacologic Substance
| - 26. MDR
- [Adaptation of tumor cells to anticancer drugs in ways that make the drugs less effective. ( NCI )] (UMLS (CSP) C0242640) =Organism Attribute ;
=drug resistance;
|
- 12. MDL-257
- (UMLS (NCI) C0127247) =Organic Chemical; Pharmacologic Substance ;
| - 27. MDR
- [Mammalian P-glycoproteins are encoded by the MDR gene family and belong to the ATP-binding cassette vectorial transport protein class; the CFTR chloride channel is also a family member. The human multidrug resistance 1 (MDR1) gene responds to environmental stress, including various anticancer agents. It is a major determinant in the development of resistance to a large number of cancer chemotherapeutic agents. MDR1 and MDR2 P-glycoproteins are large apical cell membrane proteins overproduced in multidrug-resistant (MDR) cancer cells resistant to diverse hydrophobic drugs. P-glycoproteins act as pumps able to extrude drugs from cells at the cost of ATP hydrolysis. MDR is primarily due to increased drug extrusion from the resistant cell. Defense against xenobiotics may be a natural function of these P-glycoproteins. ( NCI )] (UMLS (NCI) C0376623) =Gene or Genome
|
- 13. MDM/ACK - Document addendum notification
- (UMLS (HL7) C1549374) =Health Care Activity =Event Type;
| - 28. MDS, U
- [A myelodysplastic syndrome characterized by neutropenia or thrombocytopenia and dysplasia restricted to neutrophil or megakaryocytic cell lines. The blasts in the bone marrow and blood are not increased. (WHO, 2001) — 2003 ( NCI )] (UMLS (NCI) C0854809) MDS-U;
Myelodysplastic Syndrome, Unclassifiable;
Unclassifiable MDS;
Unclassifiable Myelodysplastic Syndrome =Neoplastic Process |
- 14. MDM/ACK - Document addendum notification and content
- (UMLS (HL7) C1549375) =Health Care Activity =Event Type;
| - 29. MDS/MPD
- [A category of clonal myeloid disorders that have both myelodysplastic and chronic myeloproliferative features at the time of initial presentation. (WHO, 2001) — 2003 ( NCI )] (UMLS (NCI) C1301355) MDS-MPD;
MPD/MDS;
MPD-MDS;
Myelodysplastic/Myeloproliferative Disease;
Myelodysplastic/Myeloproliferative Diseases;
Myelodysplastic/Myeloproliferative Disorder;
Myelodysplastic/Myeloproliferative Disorders;
Myeloproliferative/Myelodysplastic Disorders;
Myeloproliferative/Myelodysplastic Syndromes =Neoplastic Process |
- 15. MDM/ACK - Document cancel notification
- (UMLS (HL7) C1549380) =Health Care Activity =Event Type;
| - 30. MDS/MPD, U
- [This entity includes cases that have clinical, laboratory, and morphologic features that support the diagnosis of both a myelodysplastic syndrome and a chronic myeloproliferative disorder, but do not meet the criteria for any of the other entities included in the myelodysplastic/myeloproliferative disease category. (WHO, 2001) — 2003 ( NCI )] (UMLS (NCI) C1328061) MDS/MPD-U;
Mixed Myelodysplastic/Myeloproliferative Disease, Unclassifiable;
Mixed Myeloproliferative/Myelodysplastic Syndrome, Unclassifiable;
Myelodysplastic/Myeloproliferative Disease, Unclassifiable;
Unclassifiable Myelodysplastic/Myeloproliferative Disease;
Unclassifiable Myeloproliferative/Myelodysplastic Syndrome =Neoplastic Process; ;
|
home
